CDSCO Issues Final Guidance: Will This Finally Clear the Path for India’s Booming Digital Health Revolution?

Clearer rules, stronger safety standards, and faster market access, India’s regulator takes a big step to support medical software innovation.

CDSCO issues final guidance on Medical Device Software, a development that is generating excitement across India’s fast-growing digital health sector. The Central Drugs Standard Control Organisation (CDSCO) has released its long-awaited final document that brings much-needed clarity to manufacturers, innovators, and developers creating software-based medical technologies.   

For years, companies working on AI-powered health tools, patient monitoring apps, and clinical decision systems have faced uncertainty about regulatory requirements. With this new guidance, that confusion is significantly reduced.

The document provides clear direction on classification, documentation, quality management, cybersecurity, risk management, and post-market obligations for Medical Device Software (MDSW), including In-Vitro Diagnostic software, under the Medical Devices Rules, 2017. It carefully explains what software falls under regulation while excluding general wellness and fitness tracking apps.

“It is intended to promote a consistent understanding and implementation of regulatory requirements while supporting innovation, patient safety, product quality, and timely market access for Medical Device Software,” said Dr Rajeev Singh Raghuvanshi, Drugs Controller General (India).

The final guidance is more detailed than the earlier draft. It places stronger emphasis on software lifecycle management, cybersecurity, Software Bill of Materials (SBOM), AI bias evaluation, usability testing in real Indian healthcare settings, and interoperability.

Key Highlights of the Guidance:

• Clear scope for regulated Medical Device Software

• Robust quality management and risk management expectations

• Strong focus on cybersecurity and data privacy

• Practical considerations for Indian clinical workflows

• Detailed post-market surveillance requirements

According to CIO Bulletin’s analysis, this timely move by CDSCO is expected to boost confidence among both Indian startups and global players looking to enter the Indian market. By balancing innovation with patient safety, the regulator is sending a strong signal that India is serious about becoming a responsible hub for digital health technologies.